The Fred Hutch Cancer Center in Seattle, which is affiliated with the University of Washington, announced eight recipients of this year’s Dr. Eddie Méndez Scholar Award. The annual awards recognize the work of exceptional early-career scientists who are studying cancer, infectious diseases, and basic sciences.
“We offer our enthusiastic congratulations to this year’s awardees, who are moving the needle forward on science that will improve lives across the world,” said Christina Termini, an assistant professor who co-directs the awards program. “Each year we choose from a competitive pool of applicants, and these recipients impressed us with their drive to make critical new discoveries with their innovative research.” Dr. Termini, who won the Dr. Eddie Méndez Scholar Award in 2020, holds a Ph.D. in biomedical sciences from the University of New Mexico.
The namesake award honors Dr. Eddie Méndez, a physician-scientist at Fred Hutch who died of cancer in 2018. A specialist in head and neck cancers, Dr. Méndez worked to save as many patients as possible and aimed to minimize negative side effects of cancer treatments. Born in Puerto Rico, he completed his residency at the University of Washington and joined Fred Hutch in 2000. He spent his career spearheading robotic surgery for head and neck tumors and was the first provider in Washington to perform the surgery.
Five of the eight recipients of this year’s Dr. Eddie Méndez Scholar Award are women.
Rachael Chanin is a postdoctoral researcher in hematology at Stanford University in California. Her doctoral work focused on understanding the causes of commensal facultative anaerobic outgrowth during episodes of intestinal inflammation. Her current research focuses on understanding the mechanisms that drive bacterial community structure changes in the gut. She earned her Ph.D. from the University of Texas Southwestern Medical Center.






